Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer

Although curative resection is the current treatment of choice for localized non-small-cell lung cancer (NSCLC), patients show a wide spectrum of survival even after complete resection of pathological stage I NSCLC. Thus, identifying molecular biomarkers that help to accurately select patients at hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Hiroaki, Miyamoto, Kazuaki, Yamashita, Yoshinori, Taniyama, Kiyomi, Mihara, Kazuko, Nishimura, Mitsuki, Okada, Morihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618624/
https://www.ncbi.nlm.nih.gov/pubmed/26276761
http://dx.doi.org/10.1002/cam4.507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618624/
https://www.ncbi.nlm.nih.gov/pubmed/26276761
http://dx.doi.org/10.1002/cam4.507

Ejemplares similares